AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31027912 — intervention group
Group type: COMPARATOR
Intervention: Support from attending physician without simulated mortality (n=12)
Number of subjects: 48
Study 28431226 — intervention group
Group type: EXPERIMENTAL
Intervention: Ames Minilet™ Lancet
Number of subjects: 762
Study 28431226 — intervention group
Group type: EXPERIMENTAL
Intervention: Accriva Diagnostics Tenderfoot®
Number of subjects: 762
Study 28431226 — intervention group
Group type: COMPARATOR
Intervention: Cardinal Health Gentleheel®
Number of subjects: 762
Study 28431226 — intervention group
Group type: COMPARATOR
Intervention: Natus Medical NeatNick™
Number of subjects: 762
Study 28431226 — intervention group
Group type: COMPARATOR
Intervention: BD Quikheel™ Lancet
Number of subjects: 762
Study 28431226 — intervention group
Group type: COMPARATOR
Intervention: Vitrex Steriheel® Baby Lancet
Number of subjects: 762
Study 26144389 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention (12 fortnightly peer-led group sessions focusing on child care and maternal wellbeing)
Number of subjects: 194
Study 26144389 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 194
Study 26144389 — intervention group
Group type: COMPARATOR
Intervention: Control (waitlist with a brief message on nutrition)
Number of subjects: 194
Study 23821088 — intervention group
Group type: EXPERIMENTAL
Intervention: Home BP telemonitoring and pharmacist case management
Number of subjects: 450
Study 23821088 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 450
Study 20975012 — intervention group
Group type: EXPERIMENTAL
Intervention: Barber-based intervention with continuous BP checks and peer-based health messaging
Number of subjects: 152
Study 20975012 — intervention group
Group type: COMPARATOR
Intervention: Standard BP pamphlets
Number of subjects: 152
Study 18095948 — intervention group
Group type: EXPERIMENTAL
Intervention: Program 1 (self-adjusted insulin dose)
Number of subjects: 78
Study 18095948 — intervention group
Group type: EXPERIMENTAL
Intervention: Program 2 (investigator-reminded insulin dose)
Number of subjects: 78
Study 15723384 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant medications
Number of subjects: 0
Study 15723384 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release delivery systems
Number of subjects: 0
Study 15723384 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line medications
Number of subjects: 0
Study 15723384 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication adjustment
Number of subjects: 0
Study 12230618 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month course of a gonadotrophin-releasing hormone analogue before surgery
Number of subjects: 126
Study 12230618 — intervention group
Group type: COMPARATOR
Intervention: Radical prostatectomy only
Number of subjects: 126
Study 9689831 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone (N)
Number of subjects: 170
Study 9689831 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 170
Study 7808649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg suppositories
Number of subjects: 99
Study 7808649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg suppositories
Number of subjects: 99
Study 7808649 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppositories
Number of subjects: 99
Study 2574192 — intervention group
Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl hydrochloride (HCl), 4 mg dose
Number of subjects: 12
Study 2574192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 4601508 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 0.25 g
Number of subjects: 2349
Study 4601508 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 1 g
Number of subjects: 2349
Study 4601508 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 2 g
Number of subjects: 2349
Study 4601508 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic dose of 4 g on the first day of illness
Number of subjects: 2349
Study 4601508 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic dose of 8 g on the first day of illness
Number of subjects: 2349
Study 4601508 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination regimen (1 g daily and 4 g on the first day of illness)
Number of subjects: 2349
Study 4601508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2349
Study 30572875 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological disease-modifying-antirheumatic-drug (DMARD) strategy
Number of subjects: 30
Study 30572875 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 30
Study 26317483 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A palmitate eye gel 0.1%
Number of subjects: 30
Study 26317483 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbomer eye gel 0.2%
Number of subjects: 30
Study 26317483 — intervention group
Group type: COMPARATOR
Intervention: No additional application of vitamin A palmitate or carbomer gel
Number of subjects: 30
Study 25270629 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutamesine 1 mg/d
Number of subjects: 60
Study 25270629 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutamesine 3 mg/d
Number of subjects: 60
Study 25270629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22765833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecallantide
Number of subjects: 141
Study 22765833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 21038648 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine intestine adjusting therapy (IAT) with electro-acupuncturing and retention enema
Number of subjects: 60
Study 21038648 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine intestine adjusting therapy (IAT)
Number of subjects: 60
Study 21038648 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug therapy and bi-level positive airway pressure ventilation
Number of subjects: 60
Study 18724788 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 183
Study 18724788 — intervention group
Group type: EXPERIMENTAL
Intervention: Hispanic background
Number of subjects: 183
Study 18724788 — intervention group
Group type: EXPERIMENTAL
Intervention: Past suicide attempt
Number of subjects: 183
Study 18724788 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher depression scores
Number of subjects: 183
Study 18724788 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cognitive scores
Number of subjects: 183
Study 18724788 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 183
Study 15807804 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic measurement using active contour algorithms
Number of subjects: 0
Study 15807804 — intervention group
Group type: COMPARATOR
Intervention: Manual measurement
Number of subjects: 0
Study 11581481 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg acetaminophen loading dose
Number of subjects: 121
Study 11581481 — intervention group
Group type: COMPARATOR
Intervention: 15 mg/kg acetaminophen maintenance dose
Number of subjects: 121
Study 9682685 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshops, materials, and ongoing advice for center leaders promoting implementation of a preventive services office system
Number of subjects: 5509
Study 7978097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine dependence treatment (consultation, 10 intervention sessions, structured relapse prevention program)
Number of subjects: 101
Study 7978097 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 101
Study 7978097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine dependence treatment
Number of subjects: 101
Study 2568064 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips TL01 (new narrow-band UVB lamp)
Number of subjects: 29
Study 2568064 — intervention group
Group type: COMPARATOR
Intervention: Philips TL12 (standard UVB lamp)
Number of subjects: 29
Study 31671276 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA+DHA supplementation (600 mg EPA and 260 mg DHA per day for 8 weeks)
Number of subjects: 19
Study 31671276 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (matching capsules for the same duration of time)
Number of subjects: 19
Study 27441600 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (6 g/day; 5:1 EPA:DHA)
Number of subjects: 2
Study 27441600 — intervention group
Group type: COMPARATOR
Intervention: Placebo (6 g/day corn/soy oil)
Number of subjects: 2
Study 25871304 — intervention group
Group type: EXPERIMENTAL
Intervention: Best medical/surgical management plus daily supplementation of vitamin B6, vitamin B12, and folic acid
Number of subjects: 3247
Study 23698211 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection (B)
Number of subjects: 40
Study 23698211 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution) (S)
Number of subjects: 40
Study 21854650 — intervention group
Group type: EXPERIMENTAL
Intervention: Krill oil (1680 mg EPA+DHA)
Number of subjects: 12
Study 21854650 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil rTAG (1680 mg EPA+DHA)
Number of subjects: 12
Study 21854650 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil EE (1680 mg EPA+DHA)
Number of subjects: 12
Study 19948978 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c) >8%
Number of subjects: 1255
Study 19948978 — intervention group
Group type: EXPERIMENTAL
Intervention: Each 1% increase in HbA(1c)
Number of subjects: 1255
Study 19948978 — intervention group
Group type: COMPARATOR
Intervention: HbA(1c) < or =6%
Number of subjects: 1255
Study 19948978 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c) levels
Number of subjects: 1255
Study 17845684 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin agonists (cisapride and mosapride)
Number of subjects: 789
Study 17845684 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosapride
Number of subjects: 789
Study 17845684 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 789
Study 17845684 — intervention group
Group type: COMPARATOR
Intervention: Control agents (dopamine antagonists: metoclopramide and domperidone; opiate agonist: trimebutine)
Number of subjects: 789
Study 15493405 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphosyllabic instruction
Number of subjects: 3
Study 15493405 — intervention group
Group type: COMPARATOR
Intervention: Whole-word instruction
Number of subjects: 3
Study 15493405 — intervention group
Group type: COMPARATOR
Intervention: No special instruction (control group)
Number of subjects: 3
Study 11219562 — intervention group
Group type: COMPARATOR
Intervention: Usual care (physician-delivered advice and follow-up)
Number of subjects: 233
Study 11219562 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic counseling (6 computer-assisted sessions by office nurses and telephone counselors)
Number of subjects: 233
Study 11360574 — intervention group
Group type: EXPERIMENTAL
Intervention: Fufang prednisone group (mixture of prednisone and EB)
Number of subjects: 65
Study 11360574 — intervention group
Group type: COMPARATOR
Intervention: Prednisone group (control)
Number of subjects: 65
Study 11360574 — intervention group
Group type: COMPARATOR
Intervention: CORT control group (experimental model)
Number of subjects: 65
Study 11360574 — intervention group
Group type: EXPERIMENTAL
Intervention: EB group (experimental research)
Number of subjects: 65
Study 7836550 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg)
Number of subjects: 22
Study 7836550 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg)
Number of subjects: 22
Study 7836550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 29581220 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan-donor fecal microbiota transplantation
Number of subjects: 20
Study 29581220 — intervention group
Group type: COMPARATOR
Intervention: Autologous fecal microbiota transplantation
Number of subjects: 20
Study 27622957 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 58
Study 27622957 — intervention group
Group type: COMPARATOR
Intervention: Occlusal stabilization splint
Number of subjects: 58
Study 24481828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided leukocyte-rich PRP injection with standardized eccentric exercises
Number of subjects: 23
Study 24481828 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided dry needling (DN) with standardized eccentric exercises
Number of subjects: 23
Study 23250159 — intervention group
Group type: COMPARATOR
Intervention: Filtek Silorane composite resin only (Group 1)
Number of subjects: 60
Study 23250159 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimpregnated glass fibers placed at gingival third (Group 2)
Number of subjects: 60
Study 23250159 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimpregnated glass fibers placed at middle third (Group 3)
Number of subjects: 60
Study 23250159 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimpregnated glass fibers placed at occlusal third (Group 4)
Number of subjects: 60
Study 20140683 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 24
Study 20140683 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 24
Study 18974704 — intervention group
Group type: EXPERIMENTAL
Intervention: Amputation of the ischemic limb
Number of subjects: 40
Study 16568436 — intervention group
Group type: EXPERIMENTAL
Intervention: T2* multiecho MRI
Number of subjects: 53
Study 14605158 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect immunofluorescence assay (IFA)
Number of subjects: 62
Study 14605158 — intervention group
Group type: COMPARATOR
Intervention: Shell vial culture (SVC)
Number of subjects: 62
Study 14605158 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine sample
Number of subjects: 62
Study 14605158 — intervention group
Group type: EXPERIMENTAL
Intervention: Throat swab
Number of subjects: 62
Study 11029730 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional appliances (Fränkel function regulators or Harvold activators)
Number of subjects: 0
Study 11029730 — intervention group
Group type: COMPARATOR
Intervention: Untreated subjects
Number of subjects: 0
Study 8742120 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 IU hGH with TPN
Number of subjects: 216
Study 8742120 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 IU hGH with HPN
Number of subjects: 216
Study 8742120 — intervention group
Group type: COMPARATOR
Intervention: TPN
Number of subjects: 216
Study 8742120 — intervention group
Group type: COMPARATOR
Intervention: HPN
Number of subjects: 216
Study 1395888 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine and pelvic irrigation with ampicillin
Number of subjects: 217
Study 1395888 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic use of penicillin+gentamycin
Number of subjects: 217
Study 1395888 — intervention group
Group type: COMPARATOR
Intervention: Control group: no antibiotics given
Number of subjects: 217
Study 4049610 — intervention group
Group type: EXPERIMENTAL
Intervention: No-catheter postoperative management
Number of subjects: 62
Study 4049610 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydraulic self-dilatation of the urethra
Number of subjects: 62
Study 31505519 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (SRI) treatment
Number of subjects: 65
Study 28933625 — intervention group
Group type: EXPERIMENTAL
Intervention: IIV4 (quadrivalent split‐virion inactivated influenza vaccine)
Number of subjects: 300
Study 28933625 — intervention group
Group type: COMPARATOR
Intervention: IIV3 (licensed split‐virion trivalent inactivated influenza vaccine)
Number of subjects: 300
Study 27349154 — intervention group
Group type: COMPARATOR
Intervention: Cerebellar a-tDCS
Number of subjects: 59
Study 27349154 — intervention group
Group type: COMPARATOR
Intervention: M1a-tDCS
Number of subjects: 59
Study 26054175 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbit White chewing gum (chewed four times per day for 15 minutes each)
Number of subjects: 0
Study 26054175 — intervention group
Group type: COMPARATOR
Intervention: No gum (control group)
Number of subjects: 0
Study 22698563 — intervention group
Group type: EXPERIMENTAL
Intervention: MECC
Number of subjects: 40
Study 22698563 — intervention group
Group type: COMPARATOR
Intervention: CECC
Number of subjects: 40
Study 20602068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuídate program
Number of subjects: 708
Study 20602068 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 708
Study 17365767 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patches
Number of subjects: 16
Study 17365767 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 16
Study 16295308 — intervention group
Group type: EXPERIMENTAL
Intervention: Service-learning project in maternal-infant health course
Number of subjects: 0
Study 12047056 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance predictions based on retention estimates
Number of subjects: 0
Study 12047056 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated test delay (15 min or 2 weeks)
Number of subjects: 0
Study 12047056 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual differences in performance
Number of subjects: 0
Study 9862513 — intervention group
Group type: EXPERIMENTAL
Intervention: 120FEC with early primary G-CSF (days 4 to 13)
Number of subjects: 66
Study 9862513 — intervention group
Group type: COMPARATOR
Intervention: 60FEC without G-CSF
Number of subjects: 66
Study 8543644 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (50 ml solution, concentration 3 mg/ml)
Number of subjects: 10
Study 8543644 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (placebo)
Number of subjects: 10
Study 2093112 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins at doses of 1 g/Kg/day
Number of subjects: 20
Study 2093112 — intervention group
Group type: COMPARATOR
Intervention: Randomized therapy (Control)
Number of subjects: 20
Study 272413 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthrinsing with sodium‐p‐toluene sulfonchloramide (chloramine‐T)
Number of subjects: 100
Study 272413 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrushing with chloramine‐T
Number of subjects: 100
Study 272413 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation with Lugol's solution
Number of subjects: 100
Study 272413 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 100
Study 30997164 — intervention group
Group type: EXPERIMENTAL
Intervention: HMS BAB training
Number of subjects: 331
Study 30997164 — intervention group
Group type: COMPARATOR
Intervention: Standard practices
Number of subjects: 331
Study 29256465 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ml of 0.9% saline solution
Number of subjects: 2
Study 29256465 — intervention group
Group type: COMPARATOR
Intervention: 250 ml of 0.9% saline solution
Number of subjects: 2
Study 26330593 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal and joint infiltration with levo-bupivacaine
Number of subjects: 66
Study 26330593 — intervention group
Group type: COMPARATOR
Intervention: Wrist block with levo-bupivacaine
Number of subjects: 66
Study 23148500 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg/day)
Number of subjects: 50
Study 23148500 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (80-320 mg/day)
Number of subjects: 50
Study 23148500 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (Amlodipine and Valsartan)
Number of subjects: 50
Study 21191380 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 12
Study 21191380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 19654333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sapropterin
Number of subjects: 0
Study 19654333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16984797 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal betamethasone treatment (single course)
Number of subjects: 43
Study 14697925 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg twice daily
Number of subjects: 8
Study 14697925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine with itraconazole
Number of subjects: 8
Study 14697925 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine alone
Number of subjects: 8
Study 11099808 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative patterning (NP) group with letter stimuli (C, N, M, J) reinforced by shock when alone but not in compound.
Number of subjects: 2
Study 11099808 — intervention group
Group type: COMPARATOR
Intervention: Control group with the same paired‐unpaired sequence but with additional nonreinforced letters (X and H).
Number of subjects: 2
Study 11099808 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative patterning (NP) group with one pair of letters reinforced as elements but not in compound.
Number of subjects: 2
Study 11099808 — intervention group
Group type: COMPARATOR
Intervention: Control group with the same paired‐unpaired sequence but with a compound containing two different letters from the reinforced ones.
Number of subjects: 2
Study 9750603 — intervention group
Group type: EXPERIMENTAL
Intervention: Emla cream + 50 vol% nitrous oxide in oxygen
Number of subjects: 75
Study 9750603 — intervention group
Group type: COMPARATOR
Intervention: Placebo + 100 vol% oxygen
Number of subjects: 75
Study 8456888 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol therapy
Number of subjects: 223
Study 8456888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 3524093 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal adjustment (with 19 patients also receiving splint therapy)
Number of subjects: 91
Study 3524093 — intervention group
Group type: COMPARATOR
Intervention: Placebo (mock adjustment)
Number of subjects: 91
Study 28701596 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 28701596 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol
Number of subjects: 60
Study 26165396 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention (diet and physical activity), delivered once a week through eight health trainer-led sessions.
Number of subjects: 1555